Literature DB >> 9664084

Defective expression of p56lck in an infant with severe combined immunodeficiency.

F D Goldman1, Z K Ballas, B C Schutte, J Kemp, C Hollenback, N Noraz, N Taylor.   

Abstract

Severe combined immune deficiency (SCID) is a heterogeneous disorder characterized by profound defects in cellular and humoral immunity. We report here an infant with clinical and laboratory features of SCID and selective CD4 lymphopenia and lack of CD28 expression on CD8(+) T cells. T cells from this patient showed poor blastogenic responses to various mitogens and IL-2. Other T cell antigen receptor- induced responses, including upregulation of CD69, were similarly inhibited. However, more proximal T cell antigen receptor signaling events, such as anti-CD3 induced protein tyrosine phosphorylation, phosphorylation of mitogen-associated protein kinase, and calcium mobilization were intact. Although p59fyn and ZAP-70 protein tyrosine kinases were expressed at normal levels, a marked decrease in the level of p56lck was noted. Furthermore, this decrease was associated with the presence of an alternatively spliced lck transcript lacking the exon 7 kinase encoding domain. These data suggest that a deficiency in p56lck expression can produce a SCID phenotype in humans.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9664084      PMCID: PMC508901          DOI: 10.1172/JCI3205

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  47 in total

1.  T cell activation via Leu-23 (CD69).

Authors:  R Testi; J H Phillips; L L Lanier
Journal:  J Immunol       Date:  1989-08-15       Impact factor: 5.422

2.  Activators of protein kinase C induce dissociation of CD4, but not CD8, from p56lck.

Authors:  T R Hurley; K Luo; B M Sefton
Journal:  Science       Date:  1989-07-28       Impact factor: 47.728

3.  Increased plasma membrane permeability to Ca2+ in anti-Ig-stimulated B lymphocytes is dependent on activation of phosphoinositide hydrolysis.

Authors:  J T Ransom; M Chen; V M Sandoval; J A Pasternak; D Digiusto; J C Cambier
Journal:  J Immunol       Date:  1988-05-01       Impact factor: 5.422

4.  Essential role for ZAP-70 in both positive and negative selection of thymocytes.

Authors:  I Negishi; N Motoyama; K Nakayama; K Nakayama; S Senju; S Hatakeyama; Q Zhang; A C Chan; D Y Loh
Journal:  Nature       Date:  1995-08-03       Impact factor: 49.962

5.  Structure and expression of lck transcripts in human lymphoid cells.

Authors:  R M Perlmutter; J D Marth; D B Lewis; R Peet; S F Ziegler; C B Wilson
Journal:  J Cell Biochem       Date:  1988-10       Impact factor: 4.429

6.  Alterations of the lymphocyte-specific protein tyrosine kinase (p56lck) during T-cell activation.

Authors:  A Veillette; I D Horak; E M Horak; M A Bookman; J B Bolen
Journal:  Mol Cell Biol       Date:  1988-10       Impact factor: 4.272

7.  Mutations of Jak-3 gene in patients with autosomal severe combined immune deficiency (SCID).

Authors:  P Macchi; A Villa; S Giliani; M G Sacco; A Frattini; F Porta; A G Ugazio; J A Johnston; F Candotti; J J O'Shea
Journal:  Nature       Date:  1995-09-07       Impact factor: 49.962

8.  An activated lck transgene promotes thymocyte development in RAG-1 mutant mice.

Authors:  P Mombaerts; S J Anderson; R M Perlmutter; T W Mak; S Tonegawa
Journal:  Immunity       Date:  1994-07       Impact factor: 31.745

Review 9.  IL-2 signaling involves recruitment and activation of multiple protein tyrosine kinases by the IL-2 receptor.

Authors:  T Taniguchi; T Miyazaki; Y Minami; A Kawahara; H Fujii; Y Nakagawa; M Hatakeyama; Z J Liu
Journal:  Ann N Y Acad Sci       Date:  1995-09-07       Impact factor: 5.691

10.  Mutation of Jak3 in a patient with SCID: essential role of Jak3 in lymphoid development.

Authors:  S M Russell; N Tayebi; H Nakajima; M C Riedy; J L Roberts; M J Aman; T S Migone; M Noguchi; M L Markert; R H Buckley; J J O'Shea; W J Leonard
Journal:  Science       Date:  1995-11-03       Impact factor: 47.728

View more
  31 in total

Review 1.  Severe combined immunodeficiency--molecular pathogenesis and diagnosis.

Authors:  H B Gaspar; K C Gilmour; A M Jones
Journal:  Arch Dis Child       Date:  2001-02       Impact factor: 3.791

Review 2.  Diagnosis of severe combined immunodeficiency.

Authors:  A R Gennery; A J Cant
Journal:  J Clin Pathol       Date:  2001-03       Impact factor: 3.411

Review 3.  Primary T-lymphocyte immunodeficiencies.

Authors:  A Fischer
Journal:  Clin Rev Allergy Immunol       Date:  2001-02       Impact factor: 8.667

Review 4.  Molecular aspects of primary immunodeficiencies: lessons from cytokine and other signaling pathways.

Authors:  Fabio Candotti; Luigi Notarangelo; Roberta Visconti; John O'Shea
Journal:  J Clin Invest       Date:  2002-05       Impact factor: 14.808

Review 5.  Consequences of a mutation in the UNC119 gene for T cell function in idiopathic CD4 lymphopenia.

Authors:  Magdalena M Gorska; Rafeul Alam
Journal:  Curr Allergy Asthma Rep       Date:  2012-10       Impact factor: 4.806

6.  Laboratory technology for population-based screening for severe combined immunodeficiency in neonates: the winner is T-cell receptor excision circles.

Authors:  Jennifer M Puck
Journal:  J Allergy Clin Immunol       Date:  2012-01-29       Impact factor: 10.793

7.  On the activation and deactivation pathways of the Lck kinase domain: a computational study.

Authors:  Josephine Alba; Edoardo Milanetti; Marco D'Abramo
Journal:  J Comput Aided Mol Des       Date:  2019-05-10       Impact factor: 3.686

Review 8.  Reducing safety-related drug attrition: the use of in vitro pharmacological profiling.

Authors:  Joanne Bowes; Andrew J Brown; Jacques Hamon; Wolfgang Jarolimek; Arun Sridhar; Gareth Waldron; Steven Whitebread
Journal:  Nat Rev Drug Discov       Date:  2012-12       Impact factor: 84.694

9.  A mutation in the human Uncoordinated 119 gene impairs TCR signaling and is associated with CD4 lymphopenia.

Authors:  Magdalena M Gorska; Rafeul Alam
Journal:  Blood       Date:  2011-12-19       Impact factor: 22.113

Review 10.  Genetics of SCID.

Authors:  Fausto Cossu
Journal:  Ital J Pediatr       Date:  2010-11-15       Impact factor: 2.638

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.